Reasons to Retain ABT Stock in Your Portfolio Now
Investors feel optimistic about Abbott's robust strength in the Core Diagnostics business. Yet, unfavorable forex impacts are concerning.
Zacks.com on MSN5d
Expanding EPD Business Supports ABT Stock Amid Macro Issues
Abbott’s ABT diversified business portfolio is well-positioned to drive continued momentum in 2024. Yet, the international ...